Cell-Based Ophthalmic Therapies Market Report, Share 2035
What Is The Expected Valuation Of The Cell-Based Ophthalmic Therapies Market In The Upcoming Years, And How Quickly Is It Set To Grow? The cell-based ophthalmic therapies market size has grown exponentially in recent years. It will grow from $1.48 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 20.9%. The growth in the historic period can be attributed to limited treatment options for degenerative eye diseases, growing prevalence of retinal and corneal disorders, increasing aging population, rising awareness of regenerative medicine, expansion of ophthalmic research infrastructure. The cell-based ophthalmic therapies market size is expected to see exponential growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to advancements in stem cell and gene editing technologies, increasing investment in regenerative ophthalmology, rising regula...